인공 혈관 시장 예측(2025-2030년)

The vascular graft market is expected to grow from USD 1.579 billion in 2025 to USD 2.038 billion in 2030, at a CAGR of 5.23%.

The global vascular graft market is experiencing significant growth, primarily driven by the rising prevalence of chronic kidney disease (CKD) and the increasing incidence of cardiovascular conditions, such as heart strokes. These health challenges necessitate advanced surgical interventions, including dialysis and coronary artery bypass grafting (CABG), which rely heavily on vascular grafts to restore or maintain critical blood flow. As the global burden of these diseases grows, the demand for reliable and effective vascular grafts continues to expand, positioning the market for sustained growth.

Key Growth Drivers

Rising Incidence of Heart Strokes

The increasing prevalence of heart disease and strokes is a major factor propelling the vascular graft market. Conditions such as coronary artery disease and microvascular flap-based reconstructions require procedures like CABG, which is among the most common cardiac surgeries globally. The growing need for these interventions drives demand for vascular grafts, which are essential for bypassing blocked arteries and restoring blood flow. The rising incidence of strokes further amplifies the need for advanced cardiovascular devices, as these conditions often necessitate surgical solutions that incorporate vascular grafts to ensure effective treatment outcomes.

Growing Prevalence of Chronic Kidney Disease

Chronic kidney disease, often progressing to end-stage renal disease (ESRD), is a significant driver of the vascular graft market. ESRD patients frequently require hemodialysis, which depends on reliable vascular access points such as arteriovenous fistulas (AVFs) or arteriovenous grafts (AVGs). Vascular grafts play a critical role in creating and maintaining these access points, enabling efficient blood filtration during dialysis. As the global incidence of CKD rises, the demand for vascular grafts to support hemodialysis continues to grow, further fueling market expansion.

Geographical Outlook

United States as a Leading Market

The United States is anticipated to be the largest and fastest-growing market for vascular grafts during the forecast period. This growth is driven by an aging population, which faces an elevated risk of vascular diseases such as atherosclerosis, coronary artery disease, peripheral artery disease, and aneurysms. These conditions often require surgical interventions, including bypass procedures and aneurysm repairs, which rely on vascular grafts to restore blood flow. The increasing prevalence of these health issues, combined with advanced healthcare infrastructure and a focus on innovative medical solutions, positions the U.S. as a key market for vascular graft adoption.

The global vascular graft market is poised for robust growth, driven by the rising prevalence of chronic kidney disease and cardiovascular conditions, particularly heart strokes. The increasing demand for dialysis and surgical interventions like CABG underscores the critical role of vascular grafts in modern healthcare. With the United States leading market expansion due to its aging population and high incidence of vascular diseases, the vascular graft market is expected to see sustained demand. As healthcare systems address these growing challenges, vascular grafts will remain essential in improving patient outcomes and supporting critical medical procedures.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2020 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Source

• Synthetic
• Semi-Synthetic
• Natural

By Indication

• Cardiovascular
• Renal Disease
• Aneurysms
• Others

By End-User

• Hospital & Clinics
• Ambulatory Surgical Centers

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Italy
• Others
• Middle East and Africa
• Saudi Arabia
• Israel
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Indonesia
• Taiwan
• Thailand
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Assumptions

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Force Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. GLOBAL VASCULAR GRAFT MARKET ANALYSIS, BY SOURCE

• 5.1. Introduction
• 5.2. Synthetic
• 5.3. Semi-Synthetic
• 5.4. Natural

6. GLOBAL VASCULAR GRAFT MARKET ANALYSIS, BY INDICATION

• 6.1. Introduction
• 6.2. Cardiovascular
• 6.3. Renal Disease
• 6.4. Aneurysms
• 6.5. Others

7. GLOBAL VASCULAR GRAFT MARKET ANALYSIS, BY END-USER

• 7.1. Introduction
• 7.2. Hospital & Clinics
• 7.3. Ambulatory Surgical Centers

8. GLOBAL VASCULAR GRAFT MARKET ANALYSIS, BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. By Source
  • 8.2.2. By Indication
  • 8.2.3. By End-User
  • 8.2.4. By Country
    • 8.2.4.1. United States
    • 8.2.4.2. Canada
    • 8.2.4.3. Mexico
• 8.3. South America
  • 8.3.1. By Source
  • 8.3.2. By Indication
  • 8.3.3. By End-User
  • 8.3.4. By Country
    • 8.3.4.1. Brazil
    • 8.3.4.2. Argentina
    • 8.3.4.3. Others
• 8.4. Europe
  • 8.4.1. By Source
  • 8.4.2. By Indication
  • 8.4.3. By End-User
  • 8.4.4. By Country
    • 8.4.4.1. UK
    • 8.4.4.2. France
    • 8.4.4.3. Germany
    • 8.4.4.4. Italy
    • 8.4.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. By Source
  • 8.5.2. By Indication
  • 8.5.3. By End-User
  • 8.5.4. By Country
    • 8.5.4.1. Saudi Arabia
    • 8.5.4.2. Israel
    • 8.5.4.3. Others
• 8.6. Asia Pacific
  • 8.6.1. By Source
  • 8.6.2. By Indication
  • 8.6.3. By End-User
  • 8.6.4. By Country
    • 8.6.4.1. Japan
    • 8.6.4.2. China
    • 8.6.4.3. India
    • 8.6.4.4. Australia
    • 8.6.4.5. South Korea
    • 8.6.4.6. Thailand
    • 8.6.4.7. Taiwan
    • 8.6.4.8. Indonesia
    • 8.6.4.9. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Emerging Players and Market Lucrativeness
• 9.3. Market Share Analysis
• 9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

• 10.1. Getinge Group
• 10.2. W.L. Gore & Associates
• 10.3. B. Braun Melsungen AG
• 10.4. LeMaitre Vascular Inc.
• 10.5. Abbott Laboratories
• 10.6. Cook Medical
• 10.7. Terumo Medical Corporation
• 10.8. Cryolife
• 10.9. Medtronic PLC
• 10.10. Endologix Inc.